Effectiveness of Vitamin E and Hydrogen-Rich Water on Radiation Therapy-Induced Adverse In Patients With Rectal Cancer
Radiation-induced Injuries in Patients With Rectal Cancer
About this trial
This is an interventional supportive care trial for Radiation-induced Injuries in Patients With Rectal Cancer
Eligibility Criteria
Inclusion Criteria:
- - Men or women.
- Older than 18 years.
- Histologically proven adenocarcinoma of the rectum.
- Underwent radiotherapy.
- Absence of any psychological, and sociological condition that potentially affects the compliance with the study protocol and follow-up schedule.
Exclusion Criteria:
- The use of anticoagulant and antiplatelet agents.
- Any disease of disorder capable of contraindicating the absorption of Vitamin E or Hydrogen water in the body of a patient being investigated.
- No known history of problems absorbing fats (e.g., Crohn disease, cystic fibrosis)
Sites / Locations
- Augusta Victoria HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Placebo Comparator
vitamin E
Hydrogen rich water
placebo
Oral intake of Vitamin E treatment will be given on a daily basis in a single-blind manner one day before the first day of RT and continued for 8 weeks. Patients in the group receiving 500 IU of d-alpha-tocopherol capsules orally (3 times daily).
Oral intake of HRW (2 ppm) treatment will be given on a daily basis in a single-blind manner one day before the first day of RT and continued for 8 weeks. The group of patients receiving Hydrogen water took an amount of 250 ml orally 3 times a day.
Oral intake of placebo will be given on a daily basis in a single-blind manner one day before the first day of RT and continued for 8 weeks. The placebo group received 3 soft gel placebo capsules containing gelatin three times a day.